- German medical equipment group seeks to streamline operations
- In-vitro diagnostics business could fetch up to $8 billion
Siemens Healthineers AG is reviewing its diagnostics segment as the German company seeks to streamline its operations, people with knowledge of the matter said.
Frankfurt-listed Siemens Healthineers is working with advisers to study options for the division, according to the people. The review could lead to a sale or carveout of its in-vitro diagnostics operations, which test samples of blood and tissue to identify diseases and infections, they said.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.